Skip to main content
Advanced Technical In the Industry Vocabulary Test

sugammadex

Pronunciation: soo-GAM-ah-dex

Selective relaxant binding agent used to rapidly reverse neuromuscular blockade from rocuronium or vecuronium.

Full Definition

Sugammadex is a modified gamma-cyclodextrin that provides rapid and predictable reversal of neuromuscular blockade induced by rocuronium or vecuronium by encapsulating these molecules. In pediatric anesthesia, sugammadex offers significant advantages over traditional reversal agents like neostigmine, including faster onset, more complete reversal, and fewer side effects. It is particularly valuable in situations requiring immediate reversal of neuromuscular blockade, such as cannot intubate-cannot ventilate scenarios or when rapid emergence is desired. The drug has revolutionized neuromuscular management in pediatric patients.

Usage

Usage note: Document specific indication for use and dose administered based on depth of blockade

In Context

  • "Sugammadex 4 mg/kg provided rapid reversal of deep neuromuscular blockade within three minutes." — Reversal documentation
  • "Emergency sugammadex administration allowed rapid recovery from cannot intubate-cannot ventilate situation." — Critical incident report

Also known as

Bridion

Contrasted with

neuromuscular blocking agents

Don't confuse with

neostigmine rocuronium

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON